Cargando…

Medications in Patients with Dementia and Behavioral Disturbance

BACKGROUND: Behavioral disturbance (BD) is common in dementia patients, with no FDA approved medications for this condition. Little data exists on the real-world medication use in this population. OBJECTIVE: To describe real-world medications use in this population. METHODS: A cross-sectional study...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Wenjun, Liu, Xinyue, Voss, Tiffini, Khalilieh, Sauzanne, Khandker, Rezaul Karim, Bortnichak, Edward, Liaw, Kai-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293669/
https://www.ncbi.nlm.nih.gov/pubmed/34368636
http://dx.doi.org/10.3233/ADR-210023
_version_ 1783725091922640896
author Zhong, Wenjun
Liu, Xinyue
Voss, Tiffini
Khalilieh, Sauzanne
Khandker, Rezaul Karim
Bortnichak, Edward
Liaw, Kai-Li
author_facet Zhong, Wenjun
Liu, Xinyue
Voss, Tiffini
Khalilieh, Sauzanne
Khandker, Rezaul Karim
Bortnichak, Edward
Liaw, Kai-Li
author_sort Zhong, Wenjun
collection PubMed
description BACKGROUND: Behavioral disturbance (BD) is common in dementia patients, with no FDA approved medications for this condition. Little data exists on the real-world medication use in this population. OBJECTIVE: To describe real-world medications use in this population. METHODS: A cross-sectional study was conducted using the MarketScan database for outpatient medications and the Cerner database for inpatient medications. The study period was Oct 2015–Jun 2018. Patients with dementia and BD were identified through ICD-10-CM. We examined outpatient medications prescribed during 6-month before or after BD event date, and inpatient medications during inpatient visits, especially on central nervous systems (CNS) drugs including antidementia drugs, antidepressants, antipsychotics, anxiolytics, and anticonvulsants. RESULTS: A total of 56,544 outpatients and 34,245 patient hospitalizations were assessed separately. Among outpatients, patients filled more medications after a BD event. The use of the five CNS drug classes generally increased after a BD event, and the largest increase was seen in antipsychotics (23%to 33%). Among inpatients, the median number of medications used in each hospitalization was 14. The use of antipsychotics was particularly high (64%), followed by anxiolytics (51%). A list of 60 unique medications were suggested to be the commonly used drugs in dementia patients with BD. CONCLUSION: In dementia patients with BD, anti-dementia medications, antidepressants, anticonvulsants, hypnotics and antipsychotics were the most used drug classes. Antidepressants and antipsychotics use were more frequent after a BD event, which suggests a need for safe drugs targeting BD in dementia patients.
format Online
Article
Text
id pubmed-8293669
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-82936692021-08-05 Medications in Patients with Dementia and Behavioral Disturbance Zhong, Wenjun Liu, Xinyue Voss, Tiffini Khalilieh, Sauzanne Khandker, Rezaul Karim Bortnichak, Edward Liaw, Kai-Li J Alzheimers Dis Rep Research Report BACKGROUND: Behavioral disturbance (BD) is common in dementia patients, with no FDA approved medications for this condition. Little data exists on the real-world medication use in this population. OBJECTIVE: To describe real-world medications use in this population. METHODS: A cross-sectional study was conducted using the MarketScan database for outpatient medications and the Cerner database for inpatient medications. The study period was Oct 2015–Jun 2018. Patients with dementia and BD were identified through ICD-10-CM. We examined outpatient medications prescribed during 6-month before or after BD event date, and inpatient medications during inpatient visits, especially on central nervous systems (CNS) drugs including antidementia drugs, antidepressants, antipsychotics, anxiolytics, and anticonvulsants. RESULTS: A total of 56,544 outpatients and 34,245 patient hospitalizations were assessed separately. Among outpatients, patients filled more medications after a BD event. The use of the five CNS drug classes generally increased after a BD event, and the largest increase was seen in antipsychotics (23%to 33%). Among inpatients, the median number of medications used in each hospitalization was 14. The use of antipsychotics was particularly high (64%), followed by anxiolytics (51%). A list of 60 unique medications were suggested to be the commonly used drugs in dementia patients with BD. CONCLUSION: In dementia patients with BD, anti-dementia medications, antidepressants, anticonvulsants, hypnotics and antipsychotics were the most used drug classes. Antidepressants and antipsychotics use were more frequent after a BD event, which suggests a need for safe drugs targeting BD in dementia patients. IOS Press 2021-06-17 /pmc/articles/PMC8293669/ /pubmed/34368636 http://dx.doi.org/10.3233/ADR-210023 Text en © 2021 – The authors. Published by IOS Press https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Report
Zhong, Wenjun
Liu, Xinyue
Voss, Tiffini
Khalilieh, Sauzanne
Khandker, Rezaul Karim
Bortnichak, Edward
Liaw, Kai-Li
Medications in Patients with Dementia and Behavioral Disturbance
title Medications in Patients with Dementia and Behavioral Disturbance
title_full Medications in Patients with Dementia and Behavioral Disturbance
title_fullStr Medications in Patients with Dementia and Behavioral Disturbance
title_full_unstemmed Medications in Patients with Dementia and Behavioral Disturbance
title_short Medications in Patients with Dementia and Behavioral Disturbance
title_sort medications in patients with dementia and behavioral disturbance
topic Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293669/
https://www.ncbi.nlm.nih.gov/pubmed/34368636
http://dx.doi.org/10.3233/ADR-210023
work_keys_str_mv AT zhongwenjun medicationsinpatientswithdementiaandbehavioraldisturbance
AT liuxinyue medicationsinpatientswithdementiaandbehavioraldisturbance
AT vosstiffini medicationsinpatientswithdementiaandbehavioraldisturbance
AT khaliliehsauzanne medicationsinpatientswithdementiaandbehavioraldisturbance
AT khandkerrezaulkarim medicationsinpatientswithdementiaandbehavioraldisturbance
AT bortnichakedward medicationsinpatientswithdementiaandbehavioraldisturbance
AT liawkaili medicationsinpatientswithdementiaandbehavioraldisturbance